After a 15-Hour Trip, Kyrsten Sinema is Pushing the MAHA Psychedelic Agenda Now
Former Arizona Senator Kyrsten Sinema has found a new cause. The Democrat turned Independent now spends her days advocating for ibogaine, a psychedelic derived from a West African shrub. She traveled to Mexico to try it herself. Now she wants the FDA to approve it.
New:Â Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
| Key Takeaways | |
|---|---|
| State Funding Secured | Texas: $50 million; Arizona: $5 million for ibogaine research |
| Political Backing | Bipartisan support spans MAGA conservatives to progressive advocates |
| Target Conditions | Traumatic brain injury, PTSD, major depressive disorder, Parkinson’s |
| FDA Goal | State funded clinical trials to build case for federal approval |
| Key Advocates | Rick Perry, Kyrsten Sinema, Robert F. Kennedy Jr. |
Do you work in the ketamine industry? We launched the Healing Health Alliance, which is the first national provider network and GPO (Group Purchasing Organization) exclusively for ketamine practitioners and clinic owners. We will bring you significant cost savings and revenue generating opportunities. There’s no cost or obligation and you can join now!
A Personal Transformation Sparked the Mission
Sinema’s interest began with her security detail member Matt Ammel. The Army Special Forces veteran suffered from migraines after a traumatic brain injury. He traveled to Mexico for ibogaine treatment. When he returned, Sinema noticed immediate changes.
The experience sent her down what she describes as an internet rabbit hole. Two weeks of research convinced her to act.
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
Building Bipartisan Coalitions
Sinema spoke recently at an Americans for Ibogaine conference in Aspen. The group was co founded by former Texas Governor Rick Perry. She described the room as mixing super conservative MAGA and MAHA supporters with full on hippies.
This unusual coalition has delivered results. Texas Governor Greg Abbott signed legislation securing $50 million for ibogaine research. Sinema lobbied Arizona Governor Katie Hobbs to include $5 million in the state budget.
Why Now Matters
Sinema believes the current administration offers a unique window. She describes it as intentionally built around disruptors. Robert Kennedy Jr. supports psychedelic medicine. The iron is hot.
The MAHA movement, she argues, aligns naturally with psychedelic research. Healthier food, fewer chemicals, and alternative treatments all share common ground.
The Road Ahead
Ibogaine remains a Schedule 1 substance. No recognized medical use exists under current federal law. Advocates hope state funded clinical trials will generate the evidence needed for FDA approval.
For veterans struggling with treatment resistant conditions, that timeline cannot move fast enough. The data on ibogaine’s impact on traumatic brain injury and PTSD continues to build. Whether the political momentum holds may determine how quickly patients gain access.
